News | February 07, 2026
Novo Nordisk threatens legal action over Hims & Hers ‘knockoff’ semaglutide pill
The pharmaceutical giant said it would pursue legal and regulatory action following Hims & Hers
The pharmaceutical giant said it would pursue legal and regulatory action following Hims & Hers
The program seeks to boost regulatory predictability, support construction of US-based manufacturing sites
The research shows 93% of global companies now cover weight-management drugs in their health insurance plans
Experts warn that illegal products may be fake, contaminated, incorrectly dosed, or contain powerful unlisted ingredients
AFib is a progressive condition where timely intervention is critical to disease management and, ultimately, the patient's quality of life
TactiFlex, the world’s first catheter with a flexible tip and contact?force sensing, allows doctors to deliver energy precisely and safely.
Tablets will be manufactured at Granules' US-based facility located in Chantilly, Virginia
It's a development that marks a potential breakthrough for people living with the rare and debilitating disease Duchenne muscular dystrophy (DMD)
_Logo_256_384.png){kind=logo}
The Vital Shape panels provide tiered assessments to detect obesity-related risks early
DUPLEX’s two-compartment, PVC- and DEHP-free design keeps medication and diluent separate until activation
Subscribe To Our Newsletter & Stay Updated
